TrialBritish journal of cancer2009

Exemestane as primary treatment of oestrogen receptor-positive breast cancer in postmenopausal women: a phase II trial.

A Barnadas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.